Furthermore, inhibitory anti-CDH11 monoclonal antibody decreased dermal thickness and fibrotic mediators in the bleomycin-induced dermal fibrosis model [59] and in a mouse model of systemic sclerosis called the tight-skin mouse [60]. The gene discussed is CDH11; the disease is systemic sclerosis.